{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:23:11Z","timestamp":1775856191217,"version":"3.50.1"},"reference-count":7,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T00:00:00Z","timestamp":1093564800000},"content-version":"vor","delay-in-days":57,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Seborrheic dermatitis is a common inflammatory skin disorder affecting 1\u20133% of the population. It is thought to be linked to dandruff via a common etiology, yeasts of the genus <jats:italic>Malassezia.<\/jats:italic> Ciclopirox is a broad\u2010spectrum, hydroxypyridone\u2010derived, synthetic antifungal agent with anti\u2010inflammatory properties.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> A total of 203 patients were enrolled in this vehicle\u2010controlled, double\u2010blind, randomized study designed to compare vehicle with three different concentrations of ciclopirox shampoo: 0.1%, 0.3% and 1%, with each applied twice a week. The main efficacy parameters were based on 6\u2010point ordinal scales describing the disease's signs and symptoms (scaling, inflammation and itching), global status of disease, and global change in disease.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> A tendency towards improvement of the sum score from baseline was found in all ciclopirox treatment groups. The most pronounced improvement was found in the ciclopirox 1% group, which changed from a baseline sum score of 8.3 to 4.4 at the end of the 4\u2010week study period (<jats:italic>P<\/jats:italic>\u2010value vs. vehicle 0.0372). In addition, the therapeutic index showed increasing efficacy with the use of increased concentrations of ciclopirox.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The study supports the use of 1% ciclopirox shampoo in the treatment of seborrheic dermatitis of the scalp. Furthermore, ciclopirox shampoo at each concentration was found to be safe and well tolerated.<\/jats:p>","DOI":"10.1111\/j.1461-1244.2004.02381.x","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T09:30:56Z","timestamp":1093599056000},"page":"9-12","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: Results of a randomized, double\u2010blind, vehicle\u2010controlled trial"],"prefix":"10.1111","volume":"43","author":[{"given":"Peter","family":"Altmeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Loprox Shampoo Dosing Concentration Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,8,27]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"401","article-title":"Quantitative microbiology in non\u2010dandruff and seborrhoeic dermatitis","volume":"64","author":"McGinley KJ","year":"1975","journal-title":"J Am Acad Derm"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb04050.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb06631.x"},{"key":"e_1_2_6_5_2","unstructured":"ChampionR BurtonJL EblingFJG eds.Rook Wilkinson & Ebling: Textbook of Dermatology 5th edn. Oxford: Blackwell Scientific Publications 1992:545\u2013552."},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-58401-5_1"},{"key":"e_1_2_6_7_2","first-page":"594","article-title":"Comparison of ciclopirox olamine 1% cream with ciclopirox 1%\u2010hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses","volume":"10","author":"Lassus A","year":"1988","journal-title":"Clin Ther"},{"key":"e_1_2_6_8_2","first-page":"237","article-title":"Neuere Untersuchungen uber die antientzundliche Wirkung topischer Anti\u2010mykotika","volume":"69","author":"Tronnier H","year":"1994","journal-title":"Z Hautkr"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1461-1244.2004.02381.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1461-1244.2004.02381.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T04:50:17Z","timestamp":1696913417000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1461-1244.2004.02381.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":7,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1461-1244.2004.02381.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1461-1244.2004.02381.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"2004-08-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}